Tyndall MW - Search Results

1

Rationale for evaluating North America's first medically supervised safer-injecting facility.

Wood E, Kerr T, Montaner JS, Strathdee SA, Wodak A, Hankins CA, Schechter MT, Tyndall MW. Wood E, et al. Among authors: tyndall mw. Lancet Infect Dis. 2004 May;4(5):301-6. doi: 10.1016/S1473-3099(04)01006-0. Lancet Infect Dis. 2004. PMID: 15120347

2

The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users.

Wood E, Kerr T, Spittal PM, Li K, Small W, Tyndall MW, Hogg RS, O'Shaughnessy MV, Schechter MT. Wood E, et al. Among authors: tyndall mw. J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):2-8. doi: 10.1097/00126334-200301010-00002. J Acquir Immune Defic Syndr. 2003. PMID: 12514408

3

An external evaluation of a peer-run "unsanctioned" syringe exchange program.

Wood E, Kerr T, Spittal PM, Small W, Tyndall MW, O'Shaughnessy MV, Schechter MT. Wood E, et al. Among authors: tyndall mw. J Urban Health. 2003 Sep;80(3):455-64. doi: 10.1093/jurban/jtg052. J Urban Health. 2003. PMID: 12930883 Free PMC article.

4

Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy.

Wood E, Montaner JS, Tyndall MW, Schechter MT, O'Shaughnessy MV, Hogg RS. Wood E, et al. Among authors: tyndall mw. J Infect Dis. 2003 Oct 15;188(8):1164-70. doi: 10.1086/378703. Epub 2003 Oct 1. J Infect Dis. 2003. PMID: 14551887

5

Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention.

Wood E, Spittal PM, Kerr T, Small W, Tyndall MW, O'Shaughnessy MV, Schechter MT. Wood E, et al. Among authors: tyndall mw. Can J Public Health. 2003 Sep-Oct;94(5):355-9. doi: 10.1007/BF03403560. Can J Public Health. 2003. PMID: 14577743 Free PMC article.

6

Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users.

Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, Tyndall MW. Wood E, et al. Among authors: tyndall mw. CMAJ. 2004 Sep 28;171(7):731-4. doi: 10.1503/cmaj.1040774. CMAJ. 2004. PMID: 15451834 Free PMC article.

7

Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users.

Wood E, Kerr T, Lloyd-Smith E, Buchner C, Marsh DC, Montaner JS, Tyndall MW. Wood E, et al. Among authors: tyndall mw. Harm Reduct J. 2004 Nov 9;1(1):9. doi: 10.1186/1477-7517-1-9. Harm Reduct J. 2004. PMID: 15535885 Free PMC article.

8

Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use.

Collins CL, Kerr T, Kuyper LM, Li K, Tyndall MW, Marsh DC, Montaner JS, Wood E. Collins CL, et al. Among authors: tyndall mw. J Urban Health. 2005 Jun;82(2):276-84. doi: 10.1093/jurban/jti051. Epub 2005 May 4. J Urban Health. 2005. PMID: 15872188 Free PMC article.

9

A description of a peer-run supervised injection site for injection drug users.

Kerr T, Oleson M, Tyndall MW, Montaner J, Wood E. Kerr T, et al. Among authors: tyndall mw. J Urban Health. 2005 Jun;82(2):267-75. doi: 10.1093/jurban/jti050. Epub 2005 May 4. J Urban Health. 2005. PMID: 15872193 Free PMC article.

10

Do supervised injecting facilities attract higher-risk injection drug users?

Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, Kerr T. Wood E, et al. Among authors: tyndall mw. Am J Prev Med. 2005 Aug;29(2):126-30. doi: 10.1016/j.amepre.2005.04.011. Am J Prev Med. 2005. PMID: 16005809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters